The role of sialic acid in the functional activity and the hepatic clearance of C1-INH
- PMID: 7451969
The role of sialic acid in the functional activity and the hepatic clearance of C1-INH
Abstract
The immunochemical properties, catabolic clearance, and organ distribution of highly purified radiolabeled human C1-INH were studied after treatment with glycosidases. The antigenicity and C1s inhibitory activity of C1-INH were unimpaired after removal of sialic acid residues (60%) or sialic acid and galactose residues (60 and 20%, respectively) with immobilized neuraminidase and beta-galactosidase. Treatment of C1-INH with neuraminidase was associated with increased cathodal migration of the glycoprotein. In vivo studies in the rabbit, however, showed that removal of sialic acid residues resulted in rapid blood clearance of C1-INH and enhanced localization of the asialo C1-INH in the liver. Subsequent removal of penultimate galactose residues returned the survival time in the circulation and organ distribution to near normal. Additionally, simultaneous infusion of asialo-C1-INH with asialo alpha 1-acid glycoprotein, a protein known to bind to hepatic asialoglycoprotein receptors, dramatically extended the intravascular survival time of asialo C1-INH. In agreement with the observations on other plasma glycoproteins, these results indicate that desialylation of C1-INH results in rapid clearance by hepatic asialoglycoprotein receptors.
Similar articles
-
Circulating cellular fibronectin may be a natural ligand for the hepatic asialoglycoprotein receptor: possible pathway for fibronectin deposition and turnover in the rat liver.Hepatology. 1998 Aug;28(2):475-85. doi: 10.1002/hep.510280227. Hepatology. 1998. PMID: 9696014
-
The critical concentration of C1-esterase inhibitor (C1-INH) in human serum preventing auto-activation of the first component of complement (C1).Mol Immunol. 2005 Apr;42(6):657-63. doi: 10.1016/j.molimm.2004.09.025. Epub 2004 Nov 23. Mol Immunol. 2005. PMID: 15781109
-
Characterization of C1 inhibitor binding to neutrophils.Immunology. 1991 May;73(1):95-101. Immunology. 1991. PMID: 2045131 Free PMC article.
-
Initial studies on the administration of C1-esterase inhibitor to patients with septic shock or with a vascular leak syndrome induced by interleukin-2 therapy.Prog Clin Biol Res. 1994;388:335-57. Prog Clin Biol Res. 1994. PMID: 7831367 Review.
-
The dual role of sialic acid in the hepatic recognition and catabolism of serum glycoproteins.Biochem Soc Symp. 1974;(40):117-24. Biochem Soc Symp. 1974. PMID: 4620379 Review. No abstract available.
Cited by
-
Biosynthesis of complement C1 inhibitor by Hep G2 cells. Reactivity of different glycosylated forms of the inhibitor with C1s.Biochem J. 1986 Jul 1;237(1):93-8. doi: 10.1042/bj2370093. Biochem J. 1986. PMID: 3099750 Free PMC article.
-
Potentiation of C1 esterase inhibitor by StcE, a metalloprotease secreted by Escherichia coli O157:H7.J Exp Med. 2004 Apr 19;199(8):1077-87. doi: 10.1084/jem.20030255. J Exp Med. 2004. PMID: 15096536 Free PMC article.
-
A bite so sweet: the glycobiology interface of tick-host-pathogen interactions.Parasit Vectors. 2018 Nov 14;11(1):594. doi: 10.1186/s13071-018-3062-7. Parasit Vectors. 2018. PMID: 30428923 Free PMC article. Review.
-
Anticoagulant SERPINs: Endogenous Regulators of Hemostasis and Thrombosis.Front Cardiovasc Med. 2022 May 3;9:878199. doi: 10.3389/fcvm.2022.878199. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35592395 Free PMC article. Review.
-
Metabolic alteration of the N-glycan structure of a protein from patients with a heterozygous protein deficiency.Biochim Biophys Acta. 2004 Dec 24;1739(1):43-9. doi: 10.1016/j.bbadis.2004.08.006. Biochim Biophys Acta. 2004. PMID: 15607116 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous